Kaori Masai

Dr. Kaori Masai

Medical Neurobiology, Okayama University, Okayama, Japan
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2015 in Science
Verified
Journal Article
Closed access
PDF file
JCJeeyun Chung
Jeeyun Chung
Federico TortaFederico Torta
Federico Torta
KMKaori Masai
Kaori Masai
LLLouise Lucast
Louise Lucast
HCHeather Czapla
Heather Czapla
PCPietro De Camilli
Pietro De Camilli
Membrane contact sites promote lipid exchange: Most membrane lipids are manufactured in the endoplasmic reticulum (ER). Different organelles and the plasma membrane (PM) have distinct phospholipid compositions. Chung et al. , working in mammalian cells, and Moser von Filseck et al. , working in yeast, both describe how a family of proteins is important in maintaining the balance of lipids within the cell. These special proteins accumulate at and tether contact sites between the ER and the PM and promote the exchange of specific phospholipids, which helps to maintain the PM's distinct identity. Science , this issue pp. 428 and 432

21 August 2021 in Neurotoxicity Research
Verified
Journal Article
Closed access
PDF file
KMKaori Masai
Kaori Masai
KKKeita Kuroda
Keita Kuroda
NINami Isooka
Nami Isooka
RKRyo Kikuoka
Ryo Kikuoka
SMShinki Murakami
Shinki Murakami
MAMasato Asanuma
Masato Asanuma

14 November 2025 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
Ikuko MiyazakiIkuko Miyazaki
Ikuko Miyazaki
NINami Isooka
Nami Isooka
RKRyo Kikuoka
Ryo Kikuoka
FIFuminori Imafuku
Fuminori Imafuku
KMKaori Masai
Kaori Masai
MAMasato Asanuma
Masato Asanuma
Exposure to pesticides, such as rotenone or paraquat, is an environmental factor that plays an important role in the pathogenesis of Parkinson's disease (PD). Rotenone induces PD-like pathology and is therefore used to develop parkinsonian animal models. Dopaminergic neurotoxicity caused by rotenone has been attributed to the inhibition of mitochondrial complex I, oxidative stress and neuroinflammation; however, the mechanisms underlying selective dopaminergic neurodegeneration by rotenone remain unclear. To resolve this, we focused on glial diversity and examined whether the brain region-specific glial response to rotenone could determine the vulnerability of dopaminergic neurons using primary cultured neurons, astrocytes and microglia from the midbrain and striatum of rat embryos and rotenone-injected PD model mice. Direct neuronal treatment with low-dose rotenone failed to damage dopaminergic neurons. Conversely, rotenone exposure in the presence of midbrain astrocyte and microglia or conditioned media from rotenone-treated midbrain glial cultures containing astrocytes and microglia produced dopaminergic neurotoxicity, but striatal glia did not. Surprisingly, conditioned media from rotenone-treated midbrain astrocytes or microglia monocultures did not affect neuronal survival. We also demonstrated that rotenone targeted midbrain astrocytes prior to microglia to induce dopaminergic neurotoxicity. Rotenone-treated astrocytes produced secreted protein acidic and rich in cysteine (SPARC) extracellularly, which induced microglial proliferation, increase in IL-1β and TNF-α, and NF-κB (p65) nuclear translocation in microglia, resulting in dopaminergic neurodegeneration. In addition, rotenone exposure caused the secretion of NFAT-related inflammatory cytokines and a reduction in the level of an antioxidant metallothionein (MT)-1 from midbrain glia. Furthermore, we observed microglial proliferation and a decrease in the number of MT-positive astrocytes in the substantia nigra, but not the striatum, of low-dose rotenone-injected PD model mice. Our data highlight that rotenone targets midbrain astrocytes, leading to SPARC secretion, which promotes the neurotoxic conversion of microglia and leads to glial dysfunction-mediated dopaminergic neurodegeneration.

1 April 2019 in Medicine
Verified
Journal Article
Open access
KMKaori Masai
Kaori Masai
YUYayoi Ueda
Yayoi Ueda
HNHiromichi Naito
Hiromichi Naito
KTKohei Tsukahara
Kohei Tsukahara
TAToshiyuki Aokage
Toshiyuki Aokage
ANAtsunori Nakao
Atsunori Nakao
Eclampsia, an obstetric emergency frequently seen in pregnant or puerperal women, is a risk factor for posterior reversible encephalopathy syndrome (PRES). Most cases of eclampsia occur postpartum. We report a woman with PRES associated with eclampsia 10 weeks post-delivery, the latest onset ever reported. A 23-year-old healthy woman presented headache and nausea 10 weeks after delivery. Two days later, she generalized tonic-clonic seizure. Her brain MRI presented the foci which is typical of PRES. The patient was diagnosed as PRES associated with eclampsia. The patient received levetiracetam and edaravone. Her clinical course was uneventful and she fully recovered without neurological complications The possible diagnosis of late onset postpartum eclampsia, even weeks post-delivery, should be considered, since initiation of early treatment averts severe complications and decreases mortality. Sharing our experience may increase awareness of PRES induced by late-onset postpartum eclampsia.

30 December 2024 in Brain Research
Verified
Journal Article
Open access
CSChiaki Sugahara
Chiaki Sugahara
KKKyohei Kin
Kyohei Kin
TSTatsuya Sasaki
Tatsuya Sasaki
SSSusumu Sasada
Susumu Sasada
SKSatoshi Kawauchi
Satoshi Kawauchi
STShota Tanaka
Shota Tanaka
Chronic traumatic encephalopathy (CTE) has attracted attention due to sports-related head trauma or repetitive mild traumatic brain injury (mTBI). However, the pathology of CTE remains underexplored. Reproducible and quantitative model of CTE has yet to be established. The aim of this study is to establish a highly reproducible model of CTE with behavioral and histological manifestations. First, the pathological symptoms of mTBI with no intracranial hemorrhage or contusion using the weight drop model of 52 g ball from a height of 30 cm was determined using hematoxylin and eosin staining. Adult rats that received single, double, or triple head impacts were compared with sham behaviorally and histologically. Results revealed that rats exposed to repetitive mTBI showed motor impairment with gradual recovery over time, which was prolonged as the number of head impact increased. Similarly, cognitive function was impaired by repetitive mTBI and the recovery depended on the number of head impact. Histologically, GFAP positive astrocytes increased with repetitive mTBI, although Iba-1 positive microglial aggregation was limited. At 4w, phosphorylated Tau significantly accumulated in the prefrontal cortex, corpus callosum, CA1, and dentate gyrus of rats that received triple mTBI, compared to sham or those exposed to single, or double mTBI. This repetitive mTBI rat model provides a highly reproducible and quantifiable brain and behavioral pathology reminiscent of CTE.

6 June 2025 in NeuroSci
Verified
Journal Article
Open access
PDF file
Ikuko MiyazakiIkuko Miyazaki
Ikuko Miyazaki
千西千春 西山
千春 西山
TNTakeru Nagoshi
Takeru Nagoshi
AMAkane Miyako
Akane Miyako
SOSuzuka Ono
Suzuka Ono
MAMasato Asanuma
Masato Asanuma
Bisphenol A diglycidyl ether (BADGE) is the main component of epoxy resin and is used for the inner coating of canned foods and plastic food containers. BADGE can easily migrate from containers and result in food contamination; the compound is known as an endocrine-disrupting chemical. We previously reported that maternal exposure to bisphenol A bis (2,3-dihydroxypropyl) ether (BADGE·2H2O), which is the most detected BADGE derivative not only in canned foods but also in human specimens, during gestation and lactation, could accelerate neuronal differentiation in the cortex of fetuses and induce anxiety-like behavior in juvenile mice. In this study, we investigated the effects of low-dose BADGE·2H2O (1–100 pM) treatment on neurites and the mechanism of neurite outgrowth in cortical neurons. BADGE·2H2O exposure significantly increased the number of dendrites and neurite length in cortical neurons; these accelerating effects were inhibited by estrogen receptor (ER) antagonist ICI 182,780 and G-protein-coupled estrogen receptor (GPER) antagonist G15. BADGE·2H2O down-regulated Hes1 expression, which is a transcriptional repressor, and increased levels of neuritogenic factor neurogenin-3 (Ngn3) in the cortical neurons; the changes were significantly blocked by G15. These data suggest that direct BADGE·2H2O exposure can accelerate neuritogenesis and outgrowth in cortical neurons through down-regulation of Hes1 and by increasing Ngn3 levels through ERs, particularly GPER.